The five-year survival rate of stage IV lung adenocarcinoma can reach about 20%~30%, which is mainly related to the specific condition, treatment and patient’s own situation, and the individual difference is large.
Stage IV lung adenocarcinoma has already belonged to advanced stage, and the cure rate itself is relatively low, but the specific needs to be judged according to the metastasis, treatment, patient’s own condition, etc. It can only be said that the five-year survival rate of most of the patients in the clinic is between 20% and 30%, which is not completely fixed.
For example, if stage IV lung adenocarcinoma patients with pleural effusion, brain metastasis, bone metastasis, etc. have already appeared, their five-year survival rate will only be 20%, and sometimes it will be even lower; if only a single part of the metastasis has appeared, the survival rate can reach about 30% through surgery and other treatments.
In addition, it is also necessary to look at the treatment plan, traditional radiotherapy, chemotherapy treatment survival rate is even lower, while targeted therapy and other can stabilize the disease and improve its survival rate. At the same time, the patient has no other underlying diseases, the treatment is well tolerated can also be appropriate to extend the survival period. If the patient has many basic diseases, poor physical condition and cannot tolerate the treatment, the survival period will be shortened significantly.
Stage IV lung adenocarcinoma patients are recommended to consult doctor in time, choose appropriate treatment plan under doctor’s guidance, and actively cooperate with treatment in order to prolong the survival period and improve the quality of life.